Literature DB >> 25695383

Association of fatty liver with cardiovascular risk factors and subclinical atherosclerosis in a Mexican population.

María Del Rocío Martínez-Alvarado, Juan Gabriel Juárez-Rojas, Aída Xóchitl Medina-Urrutia, Guillermo Celestino Cardoso-Saldaña, María Del Carmen González-Salazar, Rosalinda Posadas-Sánchez, Esteban Jorge-Galarza, Enrique Mendoza-Pérez, Gilberto Vargas-Alarcón, Carlos Posadas-Romero1.   

Abstract

INTRODUCTION: Individuals with fatty liver (FL) have an increased risk of coronary artery disease (CAD) probably due to its association with cardiometabolic risk factors (CMRF).
OBJECTIVE: To know the prevalence of FL and analyze its association with CMRF and subclinical atherosclerosis, in a sample of Mexican Mestizo population.
MATERIAL AND METHODS: This study included 846 subjects from the Genetic of Atherosclerosis Disease (GEA) study (53 ± 9 years, 50.7% women) without diabetes and no personal or family history of premature CAD. Blood samples were taken for measurements of lipids profile, uric acid, and insulin. The presence of FL was identified by computed tomography. Carotid intima media thickness (CIMT) was measured by B mode ultrasound, using the > 75 percentile as cutoff value to define subclinical atherosclerosis.
RESULTS: The general prevalence of FL was 32.4%. In men, FL was associated with hyperuricemia, whereas in women, hyperuricemia, low level of high density lipoprotein cholesterol, and metabolic syndrome were the factors associated with this hepatic alteration. In women, FL was associated with a 66% higher probability of having high CIMT, independently of age, hypertension, dyslipidemia, and waist circumference, but not of HOMA-IR.
CONCLUSIONS: In women, FL was associated with the presence of subclinical atherosclerosis independently of traditional CMRF. Our study suggests that, in women, insulin resistance could be a mediator of metabolic abnormalities and of subclinical atherosclerosis.

Entities:  

Mesh:

Year:  2014        PMID: 25695383

Source DB:  PubMed          Journal:  Rev Invest Clin        ISSN: 0034-8376            Impact factor:   1.451


  4 in total

Review 1.  NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk.

Authors:  Stefano Ballestri; Fabio Nascimbeni; Enrica Baldelli; Alessandra Marrazzo; Dante Romagnoli; Amedeo Lonardo
Journal:  Adv Ther       Date:  2017-05-19       Impact factor: 3.845

Review 2.  Cardiovascular Risk in Fatty Liver Disease: The Liver-Heart Axis-Literature Review.

Authors:  Abdulrahman Ismaiel; Dan L Dumitraşcu
Journal:  Front Med (Lausanne)       Date:  2019-09-13

3.  Chia (Salvia hispanica)-supplemented diet ameliorates non-alcoholic fatty liver disease and its metabolic abnormalities in humans.

Authors:  Aida Medina-Urrutia; Angel R Lopez-Uribe; Mohamed El Hafidi; Maria Del Carmen González-Salazar; Rosalinda Posadas-Sánchez; Esteban Jorge-Galarza; Leonardo Del Valle-Mondragón; Juan G Juárez-Rojas
Journal:  Lipids Health Dis       Date:  2020-05-19       Impact factor: 3.876

4.  Association between non-alcoholic fatty liver disease and subclinical atherosclerosis in Western and Asian cohorts: an updated meta-analysis.

Authors:  Mark Yu Zheng Wong; Jonathan Jiunn Liang Yap; Rehena Sultana; Mark Cheah; George Boon Bee Goh; Khung Keong Yeo
Journal:  Open Heart       Date:  2021-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.